Matthew Robson Email & Phone Number
Chief Medical Officer Japan, Novartis Innovative Medicines International @ Novartis
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Matthew Robson Location
- Tokyo, JP
Matthew Robson Work
- Advisor @ (August 2026 - Present)
- Chief Medical Officer Japan, Novartis Innovative Medicines International @ (June 2022 - Present)
- Chief Scientific Officer, Novartis Pharma Japan @ (August 2020 - June 2022)
- Global Head Medical Affairs, Cell and Gene Therapies Unit @ (April 2018 - August 2020)
- Vice President, Hematology and CART, US Clinical Development and Medical Affairs @ (May 2017 - April 2018)
- Vice President, Global Clinical Research, Immuno-Oncology @ (September 2015 - April 2017)
- Clinical Head, Translational Clinical Oncology @ (August 2014 - August 2015)
- Head, Oncology Translational Medicine Japan @ (January 2011 - July 2014)
- Clinical Program Leader @ (April 2010 - January 2011)
- Senior Global Clinical Leader @ (November 2007 - June 2010)
- Director, Medical Safety Operations @ (October 2006 - November 2007)
- Oncology Project Liaison, Clinical Quality Assurance @ (October 2005 - September 2006)
- Medical Advisor @ (January 2004 - September 2005)
- Risk Manager, Senior Medical Claims Handler @ (January 1999 - December 2003)
- Fellow, Pediatric Hematology and Oncology @ Royal Children's Hospital, Melbourne (February 1997 - October 1999)
- Fellow, Bone Marrow Transplantation @ Bristol Royal Hospital for Children (August 1996 - January 1997)
Matthew Robson Education
- University of Bristol
MB ChB (Medicine)
1988-1993 - Repton School 1986-1988
Matthew Robson Skills
- Biomarkers
- Biotechnology
- CTMS
- Cancer
- Classical piano
- Clinical
- Clinical Development
- Clinical Research
- Clinical Trials
- Clinical quality assurance
- Drug Development
- FDA/EMA submission and approval
- GCP
- ICH-GCP
- Life Sciences
- Medical Affairs
- Medical Writing
- Medical litigation
- Medicine
- Oncology
- Oncology drug development (phases I-III)
- Pediatrics
- People management in a cross-cultural setting
- Pharmaceutical Industry
- Pharmacovigilance
- Post-marketing safety
- Protocol
- Protocol Development
- Quality Assurance
- Regulatory Submissions
- Strategy
- Taxi and restaurant Japanese
- Therapeutic Areas
- Translational Medicine
- Ich Gcp
- Oncology Drug Development Phases I Iii
- Sales
- Post Marketing Safety
- Fda/Ema Submission
- Strategic Planning
- Oncology Drug
- Clinical Quality
- Program Management
- Training
- Taxi And Restaurant
- People Management In A Cross Cultural Setting
- Project Management
- Oncology Drug Development
Matthew Robson Summary
- Matthew Robson, based in Tokyo, JP, is currently a Chief Medical Officer Japan, Novartis Innovative Medicines International at Novartis. Matthew Robson brings experience from previous roles at Novartis. Matthew Robson holds a 1988 - 1993 MB ChB in Medicine @ University of Bristol. With a robust skill set that includes Biomarkers, Biotechnology, CTMS, Cancer, Classical piano and more. Matthew Robson has 1 emails on RocketReach.
Looking for a different Matthew Robson?
Find contact details for 700 million professionals.
Others Named Matthew Robson
Matthew Robson
Director
Stockton-on-Tees, GB
Top Novartis Employees
Luca Barbanti
CFO Western Europe Countries
Switzerland
Pedro Barreiros
CFO Global Health
Basel, BS, CH
Jesus Acebillo
CEO Novartis Pharma, Spain
Zug, ZG, CH
Malini Sundaram
CFO Europe
Switzerland
Lars Windhorn
CFO at Novartis Pharma Switzerland
Zurich, Switzerland
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co